Wakasugi, H., Takahashi, H., Niinuma, T., Kitajima, H., Oikawa, R., Matsumoto, N., Takeba, Y., Otsubo, T., Takagi, M., Ariizumi, Y., Suzuki, M., Okuse, C., Iwabuchi, S., Nakano, M., Akutsu, N., Kang, J., Matsui, T., Yamada, N., Sasaki, H., Yamamoto, E., Kai, M., Sasaki, Y., Sasaki, S., Tanaka, Y., Yotsuyanagi, H., Tsutsumi, T., Yamamoto, H., Tokino, T., Nakase, H., Suzuki, H., & Itoh, F. (2018). dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment. Cancer letters, 434, 91–100. http://access.bl.uk/ark:/81055/vdc_100066562214.0x000038